Biofil Chemicals & Pharma Balance Sheet Annual

BSE: 524396 | NSE: BIOFILCHEM | ISIN: INE829A01014 | Sector: Biotechnology & Drugs

62.35 +0.10 (0.16%)Updated : 27 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash Equivalents	0.09	0.03	0.14	0.44
Short Term Investments	2.19	0.01	-	-
Cashand Short Term Investments	2.28	0.04	0.14	0.44
Accounts Receivable- Trade Net	33.03	20.50	7.17	17.22
Total Receivables Net	33.03	20.50	7.17	17.22
Total Inventory	2.55	1.21	1.29	4.34
Other Current Assets Total	0.55	0.65	0.70	1.46
Total Current Assets	38.41	22.41	9.31	23.46
Property/ Plant/ Equipment Total- Net	8.62	9.00	9.42	9.78
Other Long Term Assets Total	0.05	-	0.00	0.00
Total Assets	47.08	31.41	18.73	33.24
Accounts Payable	27.55	12.65	0.60	15.85
Notes Payable/ Short Term Debt	0.44	0.53	0.46	0.43
Other Currentliabilities Total	0.53	0.55	0.43	0.33
Total Current Liabilities	28.52	13.73	1.49	16.75
Total Debt	0.44	0.53	0.46	0.57
Deferred Income Tax	0.36	0.38	0.40	0.36
Total Liabilities	28.88	14.10	1.89	17.11
Common Stock Total	16.27	16.27	16.27	16.27
Retained Earnings( Accumulated Deficit)	1.93	-0.70	-1.16	-1.87
Total Equity	18.20	17.30	16.84	16.13
Total Liabilities Shareholders' Equity	47.08	31.41	18.73	33.24
Total Common Shares Outstanding	1.63	1.63	1.63	1.63
Tangible Book Valueper Share Common Eq	11.19	10.63	10.35	9.91
Total Long Term Debt	-	0.00	0.00	0.00
Additional Paid- In Capital	-	1.73	1.73	1.73
Current Portof LT Debt/ Capital Leases	-	-	-	0.14